Delivery Order SPE2DR25D3104-SPE2DR26FE9BK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,532.95 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a firm fixed price structure. The award, issued on December 15, 2025, is a non-set-aside, competitively awarded contract with an ultimate completion date of December 16, 2025. This delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,595.64 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on December 4, 2025, with completion scheduled for December 5, 2025. This non-competitive, firm fixed-price delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract represents a single pharmaceutical procurement supporting federal medical supply needs, leveraging AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,607.95 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on December 16, 2025, with an ultimate completion date of December 17, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a contract ceiling value of $9,131.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a $5,011.68 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a completion deadline of December 5, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $6,130.99 under a firm fixed-price arrangement, with an ultimate completion date of November 17, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,347.70 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (orally disintegrating tablets) 4 mg in a 30-count package, with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 18, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with the agency. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) valued at $4,476.57 with a firm fixed price structure. This non-set-aside contract, which will be completed by December 17, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $33,081.12 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $41,606.24 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement for pharmaceutical products supporting federal medical supply needs. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D3104Indefinite Delivery Contract
- SPE2DR25D3104-SPE2DR26FE9BKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,078.86 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The contract was performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, leverages this contract vehicle to deliver critical medical commodities including specialty medications, brand-name and generic drugs, and vaccines to customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 12/16/25 |